Gene · 634
Papers3,222
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 3,222
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic Thrombocytopenia. | Thromb Haemost | 2021 | 33946120 | PubTator, text mining | PubMed |
| Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice. | iScience | 2021 | 33937725 | PubTator, text mining | PubMed |
| Maintenance of Barrier Tissue Integrity by Unconventional Lymphocytes. | Front Immunol | 2021 | 33936115 | PubTator, text mining | PubMed |
| Promising role of defensins peptides as therapeutics to combat against viral infection. | Microb Pathog | 2021 | 33933603 | PubTator, text mining | PubMed |
| Identification of inhibitory immune checkpoints and relevant regulatory pathways in breast cancer stem cells. | Cancer Med | 2021 | 33932112 | PubTator, text mining | PubMed |
Identification of a Candidate Gene Set Signature for the Risk of Progression in IgM MGUS to Smoldering/Symptomatic Waldenström Macroglobulinemia (WM) by a Comparative Transcriptome Analysis of B Cells and Plasma Cells. | Cancers (Basel) | 2021 | 33921415 | PubTator, text mining | PubMed |
| Immune Checkpoints in Pediatric Solid Tumors: Targetable Pathways for Advanced Therapeutic Purposes. | Cells | 2021 | 33920505 | PubTator, text mining | PubMed |
| The Immunomodulatory CEA Cell Adhesion Molecule 6 (CEACAM6/CD66c) Is a Protein Receptor for the Influenza a Virus. | Viruses | 2021 | 33919410 | PubTator, text mining | PubMed |
| Cyanide Poisoning Compromises Gene Pathways Modulating Cardiac Injury in Vivo. | Chem Res Toxicol | 2021 | 33914522 | PubTator, text mining | PubMed |
| Vibrio cholerae toxin coregulated pilus provokes inflammatory responses in Coculture model of Caco-2 and peripheral blood mononuclear cells (PBMC) leading to increased colonization. | Microbiol Immunol | 2021 | 33913531 | PubTator, text mining | PubMed |
| A Preliminary Investigation on Plasma Cell Adhesion Molecules Levels by Protein Microarray Technology in Major Depressive Disorder. | Front Psychiatry | 2021 | 33912082 | PubTator, text mining | PubMed |
| Positive natural selection in primate genes of the type I interferon response. | BMC Ecol Evol | 2021 | 33902453 | PubTator, text mining | PubMed |
| The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy. | Cancer Lett | 2021 | 33895262 | PubTator, text mining | PubMed |
| Extensive cytokine analysis in synovial fluid of osteoarthritis patients. | Cytokine | 2021 | 33895075 | PubTator, text mining | PubMed |
| Transcriptomic Changes and the Roles of Cannabinoid Receptors and PPARγ in Developmental Toxicities Following Exposure to Δ9-Tetrahydrocannabinol and Cannabidiol. | Toxicol Sci | 2021 | 33892503 | PubTator, text mining | PubMed |
| Analysis of differences in the transcriptomic profiles of eutopic and ectopic endometriums in women with ovarian endometriosis. | PeerJ | 2021 | 33868805 | PubTator, text mining | PubMed |
| In silico Identification of 10 Hub Genes and an miRNA-mRNA Regulatory Network in Acute Kawasaki Disease. | Front Genet | 2021 | 33868359 | PubTator, text mining | PubMed |
| Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers. | EBioMedicine | 2021 | 33862588 | PubTator, text mining | PubMed |
| Impact of variant-level batch effects on identification of genetic risk factors in large sequencing studies. | PLoS One | 2021 | 33861770 | PubTator, text mining | PubMed |
| Sialylated immunoglobulin G: a promising diagnostic and therapeutic strategy for autoimmune diseases. | Theranostics | 2021 | 33859756 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/634/papers?page=61